Biotech
CHICAGO, IL: Will Distribute NanoInk's NLP 2000 System and DPN 5000 System ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 01/15/13 -- Ceapro Inc. (TSX VENTURE: CZO) today announced the granting of stock options to its employees, directors, and officers for a total of 1,400,000 stock ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 01/14/13 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and de ...
TORRANCE, CA: TORRANCE, CA -- (Marketwire) -- 01/14/13 -- ., the leader in the design and manufacture of high-performance protective case solutions and advanced portable lighting systems, today announced the acqui ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 01/14/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that all of the closing conditions have been fulfil ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 01/14/13 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) announced today that it intends to seek a voluntary delisting from the NASDAQ Global Market (NASDAQ).O ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 01/11/13 -- Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) today announced that the Company has responded to the purported termination ...
WINNIPEG, MANITOBA: Three-Year Collaborative Research Program on Preeclampsia Technology Concludes with License of Promising Marker Endoglin ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/10/13 -- Calyx Bio-Ventures Inc. ("Calyx" or the "Company") (TSX VENTURE: CYX) announced today that the analysis on the world ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 01/09/13 -- Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) has today announced that on January 8, 2013, it received from Immunovative T ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 01/08/13 -- Paladin Labs Inc. (TSX: PLB) announced today that it has entered into an exclusive Canadian distribution agreement with Allergy Therapeutics plc (AIM: ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 01/08/13 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic" or the "Corporation") announced today that it has finalized the $10 million strate ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 01/07/13 -- Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market its new 25-Hydroxy Vitamin D ...
GLOSTRUP, DENMARK: GLOSTRUP, DENMARK -- (Marketwire) -- 01/07/13 -- Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/07/13 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX: FLU)(PINKSHEETS: ATTBF) announces the engagement of Geor ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 01/07/13 -- AntriaBio, Inc., a biopharmaceutical company developing novel therapeutics for the diabetes market, is pleased to announce the acquisition of the signifi ...
PARSIPPANY, NJ and REDWOOD CITY, CA: PARSIPPANY, NJ and REDWOOD CITY, CA -- (Marketwire) -- 01/07/13 -- The Medicines Company (NASDAQ: MDCO) announced today that it has completed its acquisition of Incline Therapeutics, Inc., a company ...
HALIFAX, NOVA SCOTIA: Study Results Show Targeted Immune Responses for All Patients Treated with Vaccine Therapy; Multiple Strong Responders Present Circulating Target Specific T Cells in Blood ...
WIXOM, MI: Results Expected in First Quarter 2013 ...
SEATTLE, WA: SEATTLE, WA -- (Marketwire) -- 01/07/13 -- (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, 49, has joined the Company as Chief Financial Officer, General Counsel and Se ...
